About Enumera Molecular
Enumera Molecular is a private company based in Ann Arbor, Michigan, incorporated in 2022 in Delaware. It has reported $31,045,344 raised in two offerings on Form D since May 2022. Its chief executive is Matthew Cooper.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jul 31, 2026 | $12,325,344of $17.3M target | 12 | $1.0M | Equity, Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock.Rule 506(b) | Form D ↗ |
| May 4, 2022 | May 17, 2022amended Aug 22, 2022 | $18,720,000of $18.9M target | 5 | $3.7M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $31,045,344 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Enumera Molecular's Form D filed Jul 31, 2026.
DK
Dan Kidle
Managing Partner, Arboretum Ventures and director
Also a director at Akadeum Life Sciences, BrightSpec and JumpCode Genomics.
EH
Elaine Heron
Board Member
SB
Sundaresh Brahmasandra
Board Member